Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

lungs

Off-patent cancer drug holds promise for severe asthma treatment

May 18, 2017 Research and Development asthma, imatinib

Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …
News

FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years

May 18, 2017 Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …
News
pills-384846_960_720

Research suggests opioid crisis stems from prescription approach

May 18, 2017 Medical Communications, Research and Development opioid crisis, opioids

The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …
News
astrazeneca_building_white

AZ launches lawsuit against former executive for defecting to GSK

May 17, 2017 Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …
News

Bayer celebrates FDA priority review for investigational blood cancer drug

May 17, 2017 Research and Development, Sales and Marketing Bayer, FDA, blood cancer

Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …
News

T cells found to ‘acquire knowledge’ to take fight to metastatic cancer

May 17, 2017 Research and Development Cancer, T cell, immunotherapy

T cells are widely known as being crucial in the fight against cancer within the body but little was known, …
News

FDA demands new warnings for J&J diabetes drug over amputation risk

May 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes

Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
News

Sangamo secures FDA’s Fast Track Designation for haemophilia candidate

May 17, 2017 Research and Development, Sales and Marketing FDA, Pfizer, Sangamo Therapeutics

Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …
News
folder

Common treatment for MS revealed to have potential adverse reactions

May 16, 2017 Manufacturing and Production, Research and Development MS, multiple sclerosis

Beta interferons are a common treatment used to manage multiple sclerosis. The treatment works by reducing and preventing the inflammation …
News
ionis

Patient death sparks safety worries in Ionis trial

May 16, 2017 Manufacturing and Production, Research and Development Ionis Pharmaceuticals

Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …
News
cuba

Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s

May 16, 2017 Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …
News
brexit_flag

Brain drain: The experts the UK may lose due to Brexit

May 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …
Feature
mosquito

Malaria expected to be eradicated from 15 Indian states by 2020

May 15, 2017 Research and Development, Sales and Marketing India, antimalarial drug resistance, malaria

In good news in the fight against antimalarial drug resistance, the Director of the National Vector Borne Disease Control Programme …
News
headquarters_2_web

Lilly’s migraine drug succeeds in Phase 3 trials

May 15, 2017 Research and Development, Sales and Marketing Eli Lilly, migraines

Eli Lilly announced the successful results of three Phase 3 trials examining the benefits of its drug, galcanezumab, in patients …
News

IFPMA appoints new Assistant Director General

May 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations has followed up its appointment of Thomas Cueni as Director General by …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026